Verbal fluency facilitated by the cholinergic blocker, scopolamine

Human Psychopharmacology

Volumn 17, Issue 1, 2002, Pages 51-59

  Pompeia S ^a   Rusted, J M ^b   Curran, H V ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anticholinergic; Clustering; Muscarinic antagonist; Scopolamine; Semantic memory; Switches; Verbal fluency

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; PLACEBO; SCOPOLAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHONEME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMANTICS; SPEECH DISCRIMINATION; TASK PERFORMANCE; TIME; VERBAL BEHAVIOR; VOCALIZATION;

ADOLESCENT; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; NEUROPSYCHOLOGICAL TESTS; PHONETICS; SCOPOLAMINE; SEMANTICS; SPEECH; VERBAL BEHAVIOR; VOCABULARY;

EID: 0036165576     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.331     Document Type: Article

References (49)

1. Effects of cholinergic blockade on language in healthy young women
2. Category norms for verbal items in 56 categories: A replication and extension of the Connecticut category norms
3. Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia
4. The use of analogue scales in rating subjective feelings
5. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by primates
6. Qualitative analysis of scopolamine-induced amnesia
7. Cholinergic 'blockade' as a model of the cognitive deficits in Alzheimer disease
8. Human memory and the cholinergic system: A relationship to ageing?
9. Scopolamine and sustained retrieval from semantic memory
10. The effects of scopolamine upon verbal memory: Evidence for an attentional hypothesis
11. Further evidence that scopolamine can improve verbal fluency
12. White matter lesions impair initiation of FAS flow
13. Effects of neuroleptic medication on the cognition of patients with schizophrenia: A review of recent studies
14. Time-course of effects of oral cinnerizine and hyocine on task performance
15. Retrieval strategy in recall of natural categories and categorised lists
16. Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications
17. The cholinergic neurotransmitter system in the human memory and dementia: A review
18. Cholinergic 'blockade' as a model for cholinergic depletion
19. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
20. Computational Analysis of Present-day American English
21. Memory I: Tests
22. The effects of scopolamine on retrieval from semantic memory
23. Combined nicotinic and muscarinic blockade in elderly normal volunteers: Cognitive, behavioral, and physiologic responses
24. Degraded knowledge representations in patients with Alzheimer's disease: Implications for models of semantic and repetition priming
25. The effects of clozapine on cognitive functioning in schizophrenia
26. Comparative study of the effects of oral and i.m. atropine and hyoscine in volunteers
27. 99mTc-exametazine in anterior cingulate cortex in Korsakoff's psychosis
28. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
29. Fluency is also predominantly affected in Swiss Alzheimer's disease patients
30. National Adult Reading Test (NART)
31. Baseline corrections in experimental and quasi experimental clinical trials
32. Age and individual differences in letter fluency
33. Verbal fluency activates the left medial temporal lobe: A functional magnetic resonance imaging study
34. The scopolamine model of dementia: Determination of central cholinomimetic effects of physostigmine on cognition and biochemical markers in man
35. THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease
36. Cholinergic blockade and the human information processing: Are we asking the right questions?
37. Cognitive predictors of incident Alzheimer's disease: A prospective longitudinal study
38. Antischizophrenic drugs and brain cholinergic receptors
39. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls
40. Differential responsivity of mood, behavior, and cognition to cholinergic agents in the elderly neuropsychiatric populations
41. Effects of scopolamine on anterograde and remote memory in humans
42. Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks
43. Clustering and switching as two components of the verbal fluency: Evidence from younger and older healthy adults
44. Clustering and switching on verbal fluency tests in Alzheimer's and Parkinson's disease
45. Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans
46. A state model for mental effort
47. Changes in semantic memory in Alzheimer's disease patients
48. Triazolam-induced changes in alcoholic thought processes
49. Deficits in memory strategy use related to prefrontal dysfunction during early development: Evidence from children with phenylketonuria